Editorial: Central sleep apnoea: Another important comorbidity in heart failure?

European Journal of Heart Failure

Volumn 12, Issue 4, 2010, Pages 309-310

  Wijkstra, Peter J ^a   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ERYTHROPOIETIN;

ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CENTRAL SLEEP APNEA SYNDROME; CLINICAL EFFECTIVENESS; COMORBIDITY; EDITORIAL; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOXEMIA; HYPOXIA; KIDNEY ISCHEMIA; KIDNEY PERFUSION; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SLEEP APNEA SYNDROME; SURVIVAL RATE; TREATMENT OUTCOME; DISEASE COURSE; METABOLISM; NOTE; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR;

COMORBIDITY; DISEASE PROGRESSION; ERYTHROPOIETIN; HEART FAILURE; HUMANS; PREVALENCE; PROGNOSIS; RISK FACTORS; SLEEP APNEA, CENTRAL;

EID: 77950214460     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq023     Document Type: Editorial

References (20)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebezaa A, Nieminen M, Priori S, Swedberg K, on behalf of the Task Force for the Diagnosis, Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Eur J Heart Fail 2008;10:933-989.
2. Störk S, Hense HW, Zentgraf C, Uebelacker I, Jahns R, Ertl G, Angermann CE. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail 2008;10:367-372.
3. Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 2003;107:727-732.
4. Vazir A, Hastings PC, Dayer M, McIntyre HF, Henein MY, Poole-Wilson PA, Cowie MR, Morrell MJ, Simonds AK. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007;9:243-250.
5. Naughton MT, Lorenzo-Filho G. Sleep in heart failure. Prog Cardiovasc Dis 2009;51: 339-349.
6. Pinna GD, Maestri R, Mortara A, Johnson P, Andrews D, Ponikowski P, Witkowski T, Robbi E, La Rovere MT, Sleight P. Pathophysiological and clinical relevance of simplified monitoring of nocturnal breathing disorders in heart failure patients. Eur J Heart Fail 2009;11:264-272.
7. Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O. Sleep disordered breathing in heart failure and normal left ventricular ejection fraction. Eur J Heart Fail 2009;11:602-608.
8. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007;49:2028-2034.
9. Calvin AD, Somers VK, Steensma DP, Perez JAR, van der Walt C, Fitz-Gibbon JM, Scott CG, Olson LJ. Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail 2010;12:354-359.
10. Belonje AM, Voors AA, van der Meer P, Van Gilst WH, Jaarsma T, Van Veldhuisen DJ. Endogenous erythropoietin and outcome in heart failure. Circulation 2010;121:245-251.
11. Lipsic E, Schoemaker RG, Van der Meer P, Voors AA, van Veldhuisen DJ, van Gilst WH. Protective effects of erythropoietin in cardiac ischemia. From bench to bedside. J Am Coll Cardiol 2006;48:2161-2167.
12. Lipsic E, Van der Meer P, Voors AA, Westenbrink BD, Van den Heuvel AF, De Boer HC, Van Zonneveld AJ, Schoemaker RG, Van Gilst WH, Van Veldhuisen DJ. A single bolus of long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study. Cardiovasc Drugs Ther 2006;20:135-141.
13. Staniforth AD, Kinnear WJM, Starling R, Hetmanski DJ, Cowley AJ. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998;19: 922-928.
14. Javaheri S. Acetazolamide improves central sleep apnea in heart failure; a double-blind, prospective study. Am J Resp Crit Care Med 2006;173:234-1227
15. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS, for the CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-2033.
16. Oldenburg O, Schmidt A, Lamp B. Adaptive servo ventilation improves cardiac function in patients with chronic heart failure and Cheyne stokes respiration. Eur J Heart Fail 2008;10:581-586.
17. Lüthje L, Renner B, Kessels R, Vollmann D, Raupach T, Gerritse B, Tasci S, Schwab JO, Zabel M, Zenker D, Schott P, Hasenfuss G, Unterberg-Buchwald C, Andreas S. Cardiac resynchronisation therapy and atrial overdrive pacing for the treatment of central sleep apnea. Eur J Heart Fail 2009; 11:273-280.
18. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Ryan C, Tomlinson G, Bradley TD, for the CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007;115:3173-3180.
19. Winnicki M, Shamsuzzaman A, Lanfranchi P, Accurso V, Olson E, Davison D, Somers VK. Erythropoietin and obstructive sleep apnea. Am J Hypertens 2004; 17:783-786.
20. Shah SJ, Gheorghiade M. Heart failure with preserved ejection fraction; treat now by treating comorbidities. JAMA 2008;23:431-433.